The NIH-funded adjuvant improves the efficacy of India’s COVID-19 vaccine. Curator and Reporter: Dr. Premalata Pati, Ph.D., Postdoc WordCloud Image Produced by Adam Tubman Anthony S. Fauci, Director of the National Institute of Allergy and Infectious Diseases (NIAID), Part of National Institute of Health (NIH) said, Ending a global pandemic demands a global response. I … Continue reading The NIH-funded adjuvant improves the efficacy of India’s COVID-19 vaccine.